STOCK TITAN

Walgreens Boots Alliance, Inc. - WBA STOCK NEWS

Welcome to our dedicated page for Walgreens Boots Alliance news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreens Boots Alliance stock.

Walgreens Boots Alliance, Inc. (WBA) is the first global pharmacy-led, health and wellbeing enterprise. Formed in December 2014 through the combination of Walgreens and Alliance Boots, the company harnesses the strengths of two iconic brands with complementary geographic footprints and a heritage that dates back over a century. WBA operates over 13,100 stores in 11 countries and has a presence in more than 25 countries, employing over 370,000 people worldwide.

WBA is the largest retail pharmacy, health, and daily living destination in the USA and Europe, with its extensive network ensuring nearly three-quarters of Americans live within five miles of a Walgreens location. The company's revenue is majorly generated from prescription drug sales, which account for about two-thirds of its overall sales. Walgreens alone contributes to 20% of total prescription revenue in the U.S.

Alongside prescription sales, WBA's operations include retail products, European drug wholesale, and healthcare services. The company is continuously expanding its services with initiatives such as Health Corner and Village Medical, aiming to create an omnichannel experience for patients and positioning itself as a one-stop healthcare provider.

In recent developments, WBA has made significant strides towards sustainability, such as reducing single-use plastic in its packaging and collaborating with industry partners for better recycling practices. The efforts are part of the company's broader Environmental, Social, and Governance (ESG) initiatives aimed at reducing its environmental impact.

Additionally, Walgreens is expanding its specialty pharmacy services through the introduction of Walgreens Specialty Pharmacy, which integrates AllianceRx and focuses on providing care for patients with complex, chronic conditions. This initiative aims to improve patient outcomes and provide greater value to payers and partners.

WBA’s specialty pharmacy business is bolstered by its subsidiary, Shields Health Solutions, which supports health systems' specialty pharmacies across the U.S. Through these efforts, Walgreens continues to play a pivotal role in the healthcare system, offering comprehensive solutions that bridge gaps in patient care.

For National Women's Health Month, Walgreens has been highlighting the contributions of its female leaders, emphasizing the importance of women's health and wellness. The company organized events focused on work-life balance, mental health, and leadership development, furthering its commitment to diversity, equity, and inclusion.

With a mission to provide joy through better health, Walgreens Boots Alliance remains a trusted name in the healthcare and retail pharmacy sectors, continuously evolving to meet the needs of its customers and communities worldwide.

Rhea-AI Summary

Walgreens Boots Alliance (WBA) has appointed Dr. William H. Shrank to its board of directors. Dr. Shrank brings significant healthcare strategy and policy expertise, having held leadership roles at Humana, CVS Health, and Andreesen Horowitz. His appointment comes at a pivotal time as WBA focuses on strategic turnaround and enhancing its community pharmacy value. CEO Tim Wentworth and Executive Chairman Stefano Pessina expressed confidence that Dr. Shrank's experience will be instrumental in driving long-term value for stakeholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
management
-
Rhea-AI Summary

Walgreens Boots Alliance (WBA) has declared a quarterly dividend of 25 cents per share, consistent with the previous quarter. The dividend will be payable on September 12, 2024, to shareholders recorded by August 21, 2024. Walgreens Boots Alliance and its predecessor, Walgreen Co., have sustained a remarkable streak of paying dividends over 367 consecutive quarters, equivalent to 91 years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
dividends
-
Rhea-AI Summary

Walgreens announced its sponsorship for the second consecutive year at the Friends for Life (FFL) conference hosted by Children with Diabetes (CWD). The event, taking place from July 9-14 in Orlando, Fla, aims to provide education and support to families living with type 1 diabetes. Walgreens will showcase a range of diabetes management products, including blood glucose meters, A1C test kits, and first-aid essentials, and highlight its use of Instacart's Scan & Pay technology for convenient purchasing. Key speakers include Tracey D. Brown, Walgreens EVP and chief customer officer, and Shauna Markes-Wilson, director of pharmacy and retail operations. The event will also focus on clinical trials and recruiting healthcare professionals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
Rhea-AI Summary

Walgreens Boots Alliance (WBA) reported its fiscal 2024 third-quarter results, revealing a complex financial landscape. The company posted a Q3 earnings per share (EPS) of $0.40, up from $0.14 in the previous year, but adjusted EPS decreased by 36.6% to $0.63 due to lower sale-leaseback gains and a challenging U.S. retail environment. Sales grew 2.6% year-over-year to $36.4 billion. However, fiscal 2024 adjusted EPS guidance has been lowered to $2.80-$2.95, reflecting ongoing challenges in the pharmacy sector and U.S. consumer market.

WBA is finalizing a multiyear footprint optimization program to close underperforming U.S. stores and plans to enhance the U.S. Retail Pharmacy experience. Despite a 2.3% increase in U.S. Retail Pharmacy sales to $28.5 billion, adjusted operating income declined by 47.9%, impacted by reimbursement pressures. The International segment saw a 2.8% sales increase to $5.7 billion, while U.S. Healthcare sales rose by 7.6% to $2.1 billion.

Year-to-date results show a 6.2% sales increase to $110.1 billion, but WBA faced a net loss of $5.6 billion, up from a $2.9 billion loss in the previous year, mainly due to significant impairment charges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.16%
Tags
-
Rhea-AI Summary

Walgreens announces a special Independence Day discount offer for veterans, active-duty military personnel, and their families. From July 4 to July 7, valid military ID holders can enjoy a 20% discount on eligible regular-price products at Walgreens and Duane Reade stores nationwide. Additionally, all customers can get a 15% discount on online orders of $35 or more from June 30 to July 6 using code STARS15. The myWalgreens loyalty program offers further savings opportunities, including up to $30 in Walgreens Cash rewards each month. Walgreens ensures convenience with in-store shopping, 1-hour and 24-hour delivery options, and 30-minute pickup services. Regular Walgreens stores will operate on standard hours during Independence Day, while some pharmacies may have hours.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
none
-
Rhea-AI Summary

On June 27, Walgreens is collaborating with KFF's Greater Than HIV initiative to offer free rapid HIV and STD testing at over 550 Walgreens stores, making it the largest National HIV Testing Day event in the nation.

The initiative also includes free rapid syphilis and/or hepatitis C testing at many locations. This partnership aims to provide accessible testing and connect individuals to local prevention and treatment services.

HIV rapid test manufacturers, including Abbott Laboratories and OraSure Technologies, are donating tests. Since 2011, the partnership has provided over 82,000 free HIV tests. This year marks the program’s highest participation level.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
Rhea-AI Summary

Walgreens Boots Alliance (Nasdaq: WBA) will announce its fiscal 2024 third-quarter results on June 27, 2024. The results will be released at 7 a.m. ET, followed by a conference call with WBA management at 8:30 a.m. ET.

The call will be simulcast on the WBA investor relations website and a replay will be available for 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
-
News
Rhea-AI Summary

Walgreens has announced a new wave of price reductions, extending their commitment to help customers save on over 1,300 products across various categories. This initiative follows similar efforts started in October 2023. Key price drops include Eucerin Advance Repair Hand Cream (now $5.99, down from $7.29) and Nice! Mini Pretzels (now $1.99, down from $2.79).

Additionally, Walgreens will reintroduce its myW Days promotional campaign in mid-July, offering personalized deals to its 110 million loyalty program members. These measures are designed to alleviate financial pressures on consumers and improve access to essential items.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
none
-
Rhea-AI Summary

Walgreens is launching its inaugural community health fair, “Walgreens en tu Comunidad,” in San Juan, Puerto Rico on June 8. The event aims to enhance access to health services and education, featuring health screenings, vaccinations, and various health-related activities. Key offerings include free HIV testing, blood pressure screenings, and routine immunizations. The fair will also provide CPR demonstrations and health education from the American Heart Association, prenatal vitamins from Vitamin Angels, and consultations from Walgreens beauty and wellness experts. Special guests include Puerto Rico senator Nitza Moran Trinidad and Walgreens' chief customer officer, Tracey Brown. The event will be held from 10 a.m. to 4 p.m. ET at the Walgreens store in Montehiedra.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.05%
Tags
none
Rhea-AI Summary

Walgreens celebrated Clinical Trials Day with an event in Boston highlighting women's health in clinical trials and healthcare innovation. Kendal Whitlock, head of digital optimization for Walgreens Clinical Trials, emphasized raising awareness about gender-specific health disparities and the importance of women's participation in medical research. Keynote speakers, including Walgreens Chief Clinical Trials Officer Ramita Tandon and Dr. Yvette Cozier, shared insights on increasing women's involvement in clinical trials. Walgreens announced a new clinical trials center in Malden and highlighted milestones, such as reaching over 4 million potential trial participants with over 60% being women.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags

FAQ

What is Walgreens Boots Alliance, Inc. (WBA)?

WBA is the first global pharmacy-led, health and wellbeing enterprise, formed by the merger of Walgreens and Alliance Boots in 2014.

How many stores does Walgreens Boots Alliance operate?

WBA operates over 13,100 stores in 11 countries and has a presence in more than 25 countries.

What are the main revenue sources for Walgreens Boots Alliance?

The main revenue sources for WBA include prescription drug sales, retail products, European drug wholesale, and healthcare services.

What recent sustainability efforts has WBA made?

WBA has reduced single-use plastic in its packaging and implemented better recycling practices as part of its Environmental, Social, and Governance (ESG) initiatives.

What is Walgreens Specialty Pharmacy?

Walgreens Specialty Pharmacy is an initiative that integrates AllianceRx and focuses on providing care for patients with complex, chronic conditions.

How does Walgreens Boots Alliance contribute to women's health?

For National Women's Health Month, Walgreens has organized events focused on work-life balance, mental health, and leadership, emphasizing the importance of women's health and wellness.

What role does Shields Health Solutions play within WBA?

Shields Health Solutions supports health systems' specialty pharmacies across the U.S., enhancing WBA's specialty pharmacy offerings.

How does Walgreens Boots Alliance ensure accessibility for its customers?

Nearly three-quarters of Americans live within five miles of a Walgreens location, making healthcare services highly accessible.

What is WBA's mission?

WBA's mission is to provide joy through better health by offering comprehensive healthcare solutions and trusted pharmacy services.

What recent expansions has WBA made in its core pharmacy business?

WBA has expanded its specialty pharmacy services with the introduction of Walgreens Specialty Pharmacy, focusing on complex and chronic conditions to improve patient outcomes.

Walgreens Boots Alliance, Inc.

Nasdaq:WBA

WBA Rankings

WBA Stock Data

9.93B
863.28M
17.43%
61.59%
5.1%
Pharmacies and Drug Stores
Retail Trade
Link
United States of America
DEERFIELD